Endocrinology

Top Story

Adherence to diabetes prevention program reduces risk for disease progression

July 29, 2016

Patients with prediabetes who adhered to a relatively low-cost, practical diabetes prevention program progressed to diabetes at a lower rate than those who attended only one program session or who received standard care, according to recent study findings.

Laura J. Gray, MSc, PhD, of the department of health sciences at the University of Leicester in the United Kingdom, and colleagues evaluated 880 participants from the previously completed Let’s Prevent Diabetes trial, a cluster randomized controlled trial that randomly assigned 43 general practices to provide patients with a type 2 diabetes prevention education program (n = 447) or usual care (n = 433).

In the Journals Plus

Thyroid cancer risk increases with hysterectomy

July 29, 2016
Among postmenopausal women, the risk for thyroid cancer is increased with hysterectomy regardless of oophorectomy status, according to recently published data. Use of…
Meeting News CoverageVideo

VIDEO: EMPA-REG, LEADER trial results produce ‘exciting time’ for diabetes care

July 29, 2016
NEW ORLEANS — The results of the EMPA-REG Outcome study and the LEADER trial have expanded physicians’ armamentariums to be able to decrease patients with…
FDA News

FDA fast-track designation granted for type 1 diabetes treatment

July 29, 2016
The FDA granted a Fast Track designation to Caladrius Biosciences Inc. for its product candidate CLBS03 for the treatment of type 1 diabetes, according to a press…
In the Journals Plus

Pioglitazone decreases diabetes, stroke risks in patients with prediabetes, cerebrovascular disease

July 29, 2016
In insulin-resistant patients with a recent ischemic stroke or transient ischemic attack, pioglitazone was shown to reduce the risk for developing type 2 diabetes and…
More News Headlines »
CME

New Treatment Paradigms for Diabetic Retinopathy: Current Status and Applications for Practice

This activity is supported by an educational grant from Genentech, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Video

VIDEO: Combination therapy is ‘the wave of the future’ for diabetes treatment

June 30, 2016
More »
Featured
Highlights from AACE

Highlights from AACE

CME

Diabetic Retinopathy: The Importance of Early Screening, Referral, and Management

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Diabetic eye disease is one of the most common causes of vision loss in the United States. As the rates of diabetes…
More »
Current Issues
View the Current Issues
morganatic-roan
morganatic-roan